26th Sidley China Life Sciences Roundtable

This half-day benchmarking event provides an intimate setting for lawyers and compliance officers to engage in an interactive dialogue on the following topics:

• From 2015 to 2025: A 10-year Overview of China’s Life Sciences Regulations — What’s Happened and What’s Next
• What “Sanctions” Mean: International Trade Compliance for Pharmaceutical and Medical Device Companies
• U.S. Outbound Investment Rules and America First Investment Policy: Impacts on Chinese Biotechs
• An introduction to the U.S. FDA Guidance for Use of AI in Drug Developments
• Compliance Essentials for Life Sciences Companies in Hong Kong

Speakers

• Chen Yang, Senior Counsel, Sidley
• Lei Li, Partner, Sidley
• Ruchun Ji, Partner, Sidley
• Shu Min Ho, Partner, Sidley

Should you have any questions, please contact sidleychinalifesciencesroundtable@sidley.com.